Terms: = Skin cancer AND TNFAIP3, TNFA1P2, 7128, ENSG00000118503, OTUD7C, MGC138687, MGC104522, A20, MGC138688, P21580 AND Treatment
5 results:
1. a20 regulates the therapeutic effect of anti-PD-1 immunotherapy in melanoma.
Guo W; Ma J; Guo S; Wang H; Wang S; Shi Q; Liu L; Zhao T; Yang F; Chen S; Chen J; Zhao J; Yu C; Yi X; Yang Y; Ma J; Ni Q; Zhu G; Gao T; Li C
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33298620
[TBL] [Abstract] [Full Text] [Related]
2. a20 promotes melanoma progression via the activation of Akt pathway.
Ma J; Wang H; Guo S; Yi X; Zhao T; Liu Y; Shi Q; Gao T; Li C; Guo W
Cell Death Dis; 2020 Sep; 11(9):794. PubMed ID: 32968045
[TBL] [Abstract] [Full Text] [Related]
3. Local Delivery of OncoVEX
Moesta AK; Cooke K; Piasecki J; Mitchell P; Rottman JB; Fitzgerald K; Zhan J; Yang B; Le T; Belmontes B; Ikotun OF; Merriam K; Glaus C; Ganley K; Cordover DH; Boden AM; Ponce R; Beers C; Beltran PJ
Clin Cancer Res; 2017 Oct; 23(20):6190-6202. PubMed ID: 28706012
[No Abstract] [Full Text] [Related]
4. MALT lymphoma: A paradigm of NF-κB dysregulation.
Du MQ
Semin Cancer Biol; 2016 Aug; 39():49-60. PubMed ID: 27452667
[TBL] [Abstract] [Full Text] [Related]
5. PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism.
Adams S; Miller GT; Jesson MI; Watanabe T; Jones B; Wallner BP
Cancer Res; 2004 Aug; 64(15):5471-80. PubMed ID: 15289357
[TBL] [Abstract] [Full Text] [Related]